"Current Pharmacogenomics and Personalized Medicine provides access to the most recent progress and opinion in this rapidly developing field and is an indispensable source of information for scientists and clinicians who want to keep in touch with the expanding interdisciplinary advancements."
Brian Tomlinson Professor of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR.
"Current Pharmacogenomics and Personalized Medicine provides interdisciplinary and integrative perspectives on most recent advances in personalized medicine. The scope of diseases and pharmaceutical outcomes covered is broad and timely. I believe the journal is an essential reading for anyone who aims to quickly grasp the cutting edge in pharmacogenomics and predictive medicine."
Sunao Kaneko President, Japanese Society of Clinical Neuropsychopharmacology
"Expert Reviews in Current Pharmacogenomics and Personalized Medicine present complicated disease processes and their treatment options in a succinct manner. They are an invaluable resource for both clinicians and biomedical scientists."
Judy Wong Canada Research Chair in Genome Maintenance, University of British Columbia, Vancouver, Canada
"Current Pharmacogenomics and Personalized Medicine integrates the advances across therapeutic areas as well as molecular, clinical and social sciences. I believe the journal will contribute to the new interdisciplinary field of personalized medicine to gain its identity and accelerate its evolution."
S. Oguz Kayaalp Professor of Pharmacology and Honorary Member, The Turkish Academy of Sciences, Ankara, Turkey
Adrián LLerena, MD, Ph.D Extremadura University Hospital and Medical School Badajoz, Extremadura Spain
Dr. Adrián LLerena M.D., Ph.D. is the Director of the Clinical Research Center in the University Hospital in Badajoz Spain. between 1989-1993 he did his post doc at Karolinska Institute Sweden focusing on Clinical Pharmacogenetics. He has published more than 170 peer reviewed papers and book chapters (h index 38 Google Schoolar). He served in different Scietific societies as IberoAmerican Society of Pharmacogenomics. He has been principal investigator in more than 30 national and european research projects. Currently he is Vicepresident of the Spanish Society of Pharmacogenetics and Pharmacogenomics and Vicepresident of the Spanish Society for Clinical Pharmacology.